These discoveries underscore the importance of researching IP-10 as a potential therapeutic target in the MPN tumor microenvironment and highlight the necessity of further studies on the exact mechanism of its role in MPN oncogenesis. Here, CXCL10 is linked to myeloproliferative disorder.